Atossa Therapeutics, Inc.

ATOSNASDAQHealthcare● Active

$4.55

+$0.08(+1.79%)

Market Cap$39181997

P/E Ratio—

52W High$19.35

52W Low$3.76

Avg Volume63K

Open$4.47

Beta1.15

Cash on Hand Financials Revenue

Atossa Therapeutics, Inc. (ATOS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ATOS · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$41.3M▼ -41.9% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$41.3M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-41.9%

vs prior fiscal year

Latest Quarter

$31.7M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$41.3MCash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$41.3MNet Cash Position

Cash vs Debt Ratio

Cash 100%Atossa Therapeutics, Inc. cash as % of market cap: 105.40%% · MCap $0BDebt 0%

Atossa Therapeutics, Inc. has a net cash position of $41.3M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$41.3M − $0 = +$41.3M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

ATOS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

ATOS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$41.3M-41.9%

Dec 31, 2024FY$71.1M-19.6%

Dec 31, 2023FY$88.5M-20.2%

Dec 31, 2022FY$110.9M-18.7%

Dec 31, 2021FY$136.4M+243.8%

ATOS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

ATOS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Atossa Therapeutics, Inc.YOU

ATOS

$41.3M$39M105.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Atossa Therapeutics, Inc. (ATOS) cash on hand as of December 31, 2025 is $41.3M, comprising $41.3M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Atossa Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Atossa Therapeutics, Inc. cash reserves or cash position.

Atossa Therapeutics, Inc. annual cash on hand history shows decreased -41.9% in 2025: decreased -41.9% in 2025. Atossa Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Atossa Therapeutics, Inc. carries total debt of $0 against cash of $41.3M, resulting in a net cash position of +$41.3M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

ATOS cash on hand · 5 questions

As of December 31, 2025, Atossa Therapeutics, Inc. (ATOS) has $41,299,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $41,299,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $31,718,000. Data sourced from the annual 10-K filing via FMP.

ATOS cash on handATOS cash reservesATOS cash 2025how much cash does ATOS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Atossa Therapeutics, Inc. · Atossa Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025